Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Gray hair can potentially be reversed, leading to new treatments.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Leflunomide is more likely to help treat alopecia areata than cause it.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Sphaeranthus indicus and silver nanoparticles can help treat liver cancer by killing cancer cells.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.